JPWO2023120555A5 - - Google Patents

Info

Publication number
JPWO2023120555A5
JPWO2023120555A5 JP2023569478A JP2023569478A JPWO2023120555A5 JP WO2023120555 A5 JPWO2023120555 A5 JP WO2023120555A5 JP 2023569478 A JP2023569478 A JP 2023569478A JP 2023569478 A JP2023569478 A JP 2023569478A JP WO2023120555 A5 JPWO2023120555 A5 JP WO2023120555A5
Authority
JP
Japan
Prior art keywords
reduced coenzyme
composition
components
mixed
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023569478A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023120555A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/047018 external-priority patent/WO2023120555A1/ja
Publication of JPWO2023120555A1 publication Critical patent/JPWO2023120555A1/ja
Publication of JPWO2023120555A5 publication Critical patent/JPWO2023120555A5/ja
Pending legal-status Critical Current

Links

JP2023569478A 2021-12-24 2022-12-21 Pending JPWO2023120555A1 (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021210433 2021-12-24
JP2022152253 2022-09-26
PCT/JP2022/047018 WO2023120555A1 (ja) 2021-12-24 2022-12-21 還元型補酵素q10の保存方法

Publications (2)

Publication Number Publication Date
JPWO2023120555A1 JPWO2023120555A1 (https=) 2023-06-29
JPWO2023120555A5 true JPWO2023120555A5 (https=) 2025-11-27

Family

ID=86902582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023569478A Pending JPWO2023120555A1 (https=) 2021-12-24 2022-12-21

Country Status (4)

Country Link
US (1) US20250100959A1 (https=)
EP (1) EP4454643A4 (https=)
JP (1) JPWO2023120555A1 (https=)
WO (1) WO2023120555A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3889481B2 (ja) 1996-08-16 2007-03-07 株式会社カネカ 医薬組成物
TWI329510B (en) * 2001-10-10 2010-09-01 Kaneka Corp Method of stabilizing reduced coenzyme q10
TW200302055A (en) * 2002-01-18 2003-08-01 Kaneka Corp Ubiquinol-enriched fat-containing foods
JP5140585B2 (ja) 2006-06-22 2013-02-06 株式会社カネカ 還元型補酵素q10含有組成物およびその製造方法
JP5244790B2 (ja) 2007-04-16 2013-07-24 株式会社カネカ 還元型補酵素q10含有粒子状組成物及びその製造方法
JP2009149584A (ja) 2007-12-21 2009-07-09 Kaneka Corp 還元型補酵素q10含有粒子状組成物及びその製造方法
WO2011132718A1 (ja) * 2010-04-20 2011-10-27 株式会社カネカ 還元型補酵素q10含有組成物とその製造方法及び安定化方法
JP5998135B2 (ja) 2011-06-24 2016-09-28 株式会社カネカ 安定性に優れた還元型補酵素q10結晶
JP6459206B2 (ja) * 2014-04-25 2019-01-30 ユーハ味覚糖株式会社 高吸収型ユビキノール製剤
TW201613561A (en) * 2014-02-17 2016-04-16 Kaneka Corp Composition comprising reduced coenzyme q10
EP3755683A1 (en) * 2018-02-23 2020-12-30 Center for Intelligent Research in Crystal Engineering, S.L. Cocrystals of ubiquinol and compositions comprising them
CN112888321A (zh) * 2018-10-26 2021-06-01 三得利控股株式会社 含有还原型辅酶q10的口服用组合物、其制造方法、变色抑制方法及变色抑制剂
CN113024362B (zh) * 2021-03-10 2022-02-15 中国科学院上海药物研究所 一种辅酶qh与烟酰胺的共晶及其制备方法和用途
JP2022152253A (ja) 2021-03-29 2022-10-12 テルモ株式会社 心拍出量計測センサーおよび心拍出量計測センサーの制御プログラム

Similar Documents

Publication Publication Date Title
Sawada et al. Peptide [4] catenane by folding and assembly
Chen et al. Pharmaceutical cocrystals of ribavirin with reduced release rates
Gruverman Mössbauer effect methodology
RU2003121236A (ru) Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием
HRP20180465T1 (hr) Kristalni oblici inhibitora faktora xia
JP2015533168A5 (https=)
Shewale et al. Formulation and solid state characterization of nicotinamide-based co-crystals of fenofibrate
JP2013539448A5 (https=)
JP2016528273A5 (https=)
Galkin et al. Modulation of the conformational state of mitochondrial complex I as a target for therapeutic intervention
JPWO2023120555A5 (https=)
JP2018522811A5 (https=)
RU2016118399A (ru) Производные 4-аминометилбензойной кислоты
Eccles et al. Crystal landscape of primary aromatic thioamides
JP2016523092A5 (https=)
Friedrich et al. Effects of combined treatment with vitamin D and COX2 inhibitors on breast cancer cell lines
Balahoju et al. Helicity modulation in nir‐absorbing porphyrin‐ryleneimides
Li et al. Magnesium lithospermate B derived from salvia miltiorrhiza ameliorates right ventricle remodeling in pulmonary hypertensive rats via inhibition of NOX/VPO1 pathway
Sauvage et al. From chemical topology to molecular machines
Baglai et al. Enantiospecific solid solution formation triggers the propagation of homochirality
Gieling et al. Mechanochemical Deracemization: A Sustainable Approach to Enantiopurity
AR061165A1 (es) Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas
Lifshits et al. A supramolecular approach for designing emissive solid-state carbazole arrays
JP2008512552A5 (https=)
García-Descalzo et al. Changes in membrane fatty acids of a halo-psychrophile exposed to magnesium perchlorate and low temperatures: implications for Mars habitability